2019 Course Highlights


These are highlights from the 2019 course. 2020 not yet available,


• Difficult cases in alcohol withdrawal

• Common pitfalls in opioid titration for acute pain

• New guidelines on the management of opioid-induced constipation

• Dangers of natural / synthetic cannabinoids

• Update on management of opioid use disorders

• New options for the palliation of nausea and vomiting



• Testing and desensitization for β-lactam allergies

• What to do when there is no allergist

• Penicillin allergy: A risk factor for MRSA and C. difficile?

• Contemporary anaphylaxis management



• Using high-sensitivity troponin and prediction scores to rule out ACS

• The evolving use of risk scores in PE workup

• CT-PE may not rule out PE in all patients

• Should we be using PCSK9 inhibitors to prevent cardiovascular events?

• The Fourth Universal Definition of Myocardial Infarction

• Update on supplemental O2 in AMI patients

• Coronary CT for chest pain triage?

• Should we give IV magnesium for rate control of atrial fibrillation?

• PE as a cause of syncope: Dangerous, but not as common as we thought?

• A salty debate: Is sodium restriction in heart failure beneficial?

• New data: Angiotensin receptor-neprilysin inhibitors in acute decompensated heart failure

• New data: Direct oral anticoagulants (DOACs) in STEMI

• Syncope: When to order ancillary testing

• Atrial fibrillation: Updates on catheter ablation and LAA occlusion



• Are patient visitors the best prevention for delirium?

• Antipsychotics for delirium: Don’t believe the hype

• Are melatonin agonists useful or not in delirium prevention?



• ECG and interpretation pearls and pitfalls

• Can’t-miss radiology diagnoses

• Rapid-fire review of laboratory cases

• Radiology: Choosing the right imaging protocols



• Rapid-fire review of insulin management cases

• More liberal targets in inpatient glucose control?

• New data on metformin safety in chronic kidney disease

• Adverse effects of SGLT-2 and DPP-4 inhibitors

• Artificial pancreas therapy in the inpatient setting?



• What imaging to order in suspected biliary obstruction

• Weekly vs. daily dosing for SBP prophylaxis

• New FDA approval: Thrombopoietin receptor agonists for periprocedural thrombocytopenia in liver disease

• More data for preemptive TIPS in high-risk acute variceal hemorrhage

• Hemostatic spray: A new therapeutic option for lower GIB



• Choosing wisely: Best practices for limiting transfusions

• Case-based review: Choosing the optimal DOAC for your patient

• Reversing anticoagulation with DOACs

• New guidelines on the management of bleeding in patients on oral anticoagulants

• L-glutamine: The first new sickle cell treatment approved in 20 years

• DOACs for heparin-induced thrombocytopenia?

• Red flags: When to call hematology



• Case-based antibiotic review and pearls for interpreting culture data

• Even more reasons to avoid fluoroquinolones

• Pneumonia: The latest on CT vs. CXR, steroids, atypical coverage, and optimal antibiotic duration

• Procalcitonin for stopping antibiotics in the ICU

• New therapies for influenza

• New antibiotics for highly drug-resistant organisms in 2019

• Early switch to oral antibiotics in left-sided endocarditis

• New data on oral antibiotics for Staph aureus bacteremia

• Bacteremia that should prompt a colonoscopy: Strep bovis and beyond

• Reducing mortality from ESBL bacteremia

• Cellulitis: Things we do for no reason

• New guidelines for C. difficile management

• Is qSOFA enough for identifying sepsis?

• Do indwelling urinary catheters need to be exchanged in UTI?



• Are we undertreating osteoporosis in hip fracture patients?

• Endocarditis from non-dental procedures?

• New data on the importance of detecting perioperative MI

• Newest data on perioperative anticoagulation, aspirin, ACE inhibitors, and beta blockers



• Should we be stopping inhaled corticosteroids in COPD with pneumonia?

• New biologic options for asthma: Anti-IgE, anti-IL4 and anti-IL5 blockers

• Supplemental oxygen: Use with caution in critical illness



• Rethinking contrast-associated acute kidney injury

• Timing of renal replacement therapy in shock

• Lactated Ringer's vs. saline in the ICU

• Pearls for managing access in hospitalized ESRD patients



• Diagnostic pearls: Exam, arthrocentesis, and laboratory tests

• Recognizing rheumatologic emergencies

• How to avoid a crash landing: Transitioning acute gout management on discharge



• New data on dual antiplatelet therapy in stroke and TIA

• Managing stroke in 2019: Beyond the TPA window

• New modality in ischemic stroke: Perfusion CT to assess salvageable penumbra

• Is MRI useful in patients with stroke of unknown onset?

• In the community: When to transfer for endovascular therapy